Imunon, Inc.
IMNN
$1.98
-$0.04-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -44.51% | 309.21% | 844.09% | 639.46% | 333.36% |
| Gross Profit | 44.51% | -309.21% | -844.09% | -639.46% | -333.36% |
| SG&A Expenses | -8.32% | -12.30% | -13.90% | -7.62% | -23.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.43% | -30.63% | -19.48% | -10.27% | -9.02% |
| Operating Income | 23.43% | 30.63% | 19.48% | 10.27% | 9.02% |
| Income Before Tax | 22.15% | 30.88% | 18.68% | 11.62% | 10.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.15% | 26.33% | 12.92% | 5.62% | 4.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.15% | 26.33% | 12.92% | 5.62% | 4.59% |
| EBIT | 23.43% | 30.63% | 19.48% | 10.27% | 9.02% |
| EBITDA | 24.00% | 30.94% | 19.58% | 10.25% | 9.09% |
| EPS Basic | 59.96% | 59.13% | 50.56% | 34.88% | 28.23% |
| Normalized Basic EPS | 59.96% | 61.94% | 53.82% | 37.95% | 31.39% |
| EPS Diluted | 59.96% | 59.13% | 50.56% | 34.88% | 28.23% |
| Normalized Diluted EPS | 59.96% | 61.94% | 53.82% | 37.95% | 31.39% |
| Average Basic Shares Outstanding | 109.53% | 97.92% | 79.73% | 54.85% | 45.39% |
| Average Diluted Shares Outstanding | 109.53% | 97.92% | 79.73% | 54.85% | 45.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |